BAP1 and nonpapillary renal cell carcinoma: In light of our prior findings demonstrating that ccRCC patients with BAP1 mutations exhibit adverse outcomes with respect to both prognosis [10] and overall survival [13], we sought to ascertain whether BAP1 levels exhibit a correlation with SRC levels.